BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16336903)

  • 1. Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV; Al Issa A; Al Eisa A; Asaad M
    Dermatol Surg; 2005 Dec; 31(12):1737-9; discussion 1740. PubMed ID: 16336903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.
    Ramos MG; Ramos DG; Ramos CG
    An Bras Dermatol; 2017; 92(3):312-318. PubMed ID: 29186240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous noncultured melanocyte-keratinocyte transplantation in stable vitiligo: A randomized comparative study of recipient site preparation by two techniques.
    Gupta S; Relhan V; Garg VK; Sahoo B
    Indian J Dermatol Venereol Leprol; 2019; 85(1):32-38. PubMed ID: 29998861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermabrasion Versus Microneedling in Transplantation of Autologous Noncultured Melanocyte-Keratinocyte Cell Suspension in Patients With Vitiligo.
    Hasan MS; Almohsen AM; Nasr MI; Rageh MA
    Dermatol Surg; 2023 May; 49(5):494-502. PubMed ID: 36892550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropunch grafting as an adjuvant for noncultured melanocyte-keratinocyte transplantation for refractory vitiligo.
    Bae JM; Ju HJ; Lee RW; Lee HN; Kim NB; Kim YH; Jung HM
    J Am Acad Dermatol; 2020 Jun; 82(6):1548-1550. PubMed ID: 32160974
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study.
    van Geel N; Ongenae K; De Mil M; Naeyaert JM
    Dermatol Surg; 2001 Oct; 27(10):873-6. PubMed ID: 11722524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
    Mulekar SV; Al Issa A; Al Eisa A
    Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases.
    Ramos MG; Ramos DG; Gontijo G; Ramos CG; Rocha TN; Rocha RH
    An Bras Dermatol; 2013; 88(5):811-3. PubMed ID: 24173191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Koebnerization of donor site in unilateral vitiligo patients, treated successfully by autologous, noncultured melanocyte-keratinocyte (MK) cell transplantation.
    Mulekar SV; Al Eissa A; Asaad M
    Clin Exp Dermatol; 2005 Jul; 30(4):445-6. PubMed ID: 15953098
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel point-of-care technique to improve graft uptake in a melanocyte-keratinocyte transplantation procedure for vitiligo of contoured areas such as the external ear.
    Akshi B; Shilpa K; Harish P
    J Am Acad Dermatol; 2022 May; 86(5):e191-e192. PubMed ID: 32497701
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
    Vakharia PP; Lee DE; Khachemoune A
    Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation of leukotrichia due to retrograde migration of melanocytes after noncultured epidermal suspension transplantation.
    Holla AP; Sahni K; Kumar R; Kanwar A; Mehta S; Parsad D
    Dermatol Surg; 2014 Feb; 40(2):169-75. PubMed ID: 24372919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of autologous melanocyte transfer in treatment of stable vitiligo.
    Pandya V; Parmar KS; Shah BJ; Bilimoria FE
    Indian J Dermatol Venereol Leprol; 2005; 71(6):393-7. PubMed ID: 16394479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
    Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte-melanocyte graft technique followed by PUVA therapy for stable vitiligo.
    Kachhawa D; Kalla G
    Indian J Dermatol Venereol Leprol; 2008; 74(6):622-4. PubMed ID: 19171987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.